ArticleHealth science reports2025
Machine Learning Algorithms for Adverse Drug Reactions Prediction and Identifying Its Determinants Among HIV Patients on Antiretroviral Therapy in the University of Gondar Comprehensive and Specialized Hospital, in Amhara Region, Ethiopia.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Harmful and unexpected reactions to drugs given at standard dosages using the appropriate administration technique for the goals of therapy, diagnosis, or prevention are known as adverse drug reactions (ADRs). Every medicine has the potential to produce both favorable and unfavorable outcomes. Information regarding the timing of adverse drug reactions and their predictors in adults is not well addressed regarding time and various predictor variables, including the study area, even though three separate studies on the adverse drug reactions of adult patients receiving antiretroviral therapy (ART) have been conducted in Ethiopia. Objective: To predict adverse drug reactions in HIV patients receiving antiretroviral medication in the University of Gondar Comprehensive and Specialized Hospital using machine learning algorithms. Methods: Using institution-based secondary data, patients receiving antiretroviral medication at the University of Gondar Comprehensive and Specialized Hospital between January 11, 2018, and January 10, 2023, were examined. Patient data was extracted from the electronic database using a methodical checklist, and it was then imported into Python version three for pre-processing and analysis. Then, seven machine learning algorithms for supervised classification were trained to create models. The prediction models were evaluated using F1-score, AUC, accuracy, sensitivity, specificity, and precision. Association rule mining was used to determine the best rule for the association between independent features and the target feature. Result: There were 3371 (64.04%) female participants and 1893 (35.06%) male individuals out of 5864 research participants. Among all the chosen classifiers, the random forest classifier (sensitivity = 1.00, precision = 0.987, f1-score = 0.993, AUC = 0.9989) fared better in predicting ADRs. Based on the importance ranking, the CD4 count was determined to be the most significant predictor feature. The top eight predictors of ADRs were identified by random forest feature importance and association rules as follows: Male, younger age, longer duration on ART, not taking Co-trimoxazole preventive therapy (CPT), not taking TB (Tuberculosis) preventive therapy (TPT), secondary educational status, TDF-3TC-EFV, and low CD4 counts. Conclusion: Our research shows that HIV patients who are at a high risk of adverse drug reactions and those who can recognize the predictive traits associated with the ADRs can be categorized according to how effectively their ART treatment is working. However, our research may help address the pressing public health issue of diagnosing and treating HIV-positive individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.